Pola-R-CHP Plus Sonrotoclax in Untreated BCL2-High/Double-Hit LBCL

Clinical trial NCT07638787 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07638787
Sponsor: Ruijin Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Large B-cell Lymphoma

Start date: 2026-06-15
Primary completion: 2027-09-30
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.